Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

被引:130
作者
Buchheit, Kathleen M. [1 ,3 ]
Cahill, Katherine N. [1 ,3 ]
Katz, Howard R. [1 ,3 ]
Murphy, Katherine C. [3 ]
Feng, Chunli [3 ]
Lee-Sarwar, Kathleen [1 ]
Lai, Juying [3 ]
Bhattacharyya, Neil [2 ,4 ]
Israel, Elliot [1 ,5 ]
Boyce, Joshua A. [1 ,3 ]
Laidlaw, Tanya M. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Otolaryngol, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Pulm Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Aspirin-exacerbated respiratory disease; Samter triad; nasal polyps; thymic stromal lymphopoietin; prostaglandin D-2; cysteinyl leukotrienes; innate immunity; mast cells; eosinophils; INNATE LYMPHOID-CELLS; HUMAN EPITHELIAL-CELLS; MAST-CELL; EOSINOPHILIC INFLAMMATION; CYSTEINYL LEUKOTRIENES; CHRONIC RHINOSINUSITIS; ALLERGIC INFLAMMATION; CYTOKINE PRODUCTION; ASTHMATIC AIRWAYS; EXPRESSION;
D O I
10.1016/j.jaci.2015.10.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Prostaglandin (PG) D-2 is the dominant COX product of mast cells and is an effector of aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease (AERD). Objective: We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells to generate PGD(2) and facilitate tissue eosinophilia and nasal polyposis in patients with AERD. Methods: Urinary eicosanoid levels were measured in aspirin-tolerant control subjects and patients with AERD. Nasal polyp specimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR, Western blotting, and immunohistochemistry. Human cord blood-and peripheral blood-derived mast cells were stimulated with TSLP in vitro to assess PGD(2) generation. Results: Urinary levels of a stable PGD(2) metabolite (uPGD-M) were 2-fold higher in patients with AERD relative to those in control subjects and increased further during aspirin-induced reactions. Peak uPGD-Mlevels during aspirin reactions correlated with reductions in blood eosinophil counts and lung function and increases in nasal congestion. Mast cells sorted from nasal polyps expressed PGD(2) synthase (hematopoietic PGD(2) synthase) mRNA at higher levels than did eosinophils from the same tissue. Whole nasal polyp TSLP mRNA expression correlated strongly with mRNA encoding hematopoietic PGD(2) synthase (r = .75), the mast cell-specific marker carboxypeptidase A3 (r = .74), and uPGD-M (r=0.74). Levels of the cleaved active form of TSLP were increased in nasal polyps from patients with AERD relative to those in aspirin-tolerant control subjects. Recombinant TSLP induced PGD(2) generation by cultured human mast cells. Conclusions: Our study demonstrates that mast cell-derived PGD(2) is a major effector of type 2 immune responses driven by TSLP and suggests that dysregulation of this innate system contributes significantly to the pathophysiology of AERD.
引用
收藏
页码:1566 / +
页数:16
相关论文
共 50 条
  • [41] Algorithmic Identification of Patients With Aspirin-Exacerbated Respiratory Disease Using an Electronic Health Record
    Tao, Michael
    Roberts, Sarah
    Arnold, Mark
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 169 (02) : 253 - 257
  • [42] Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: A cross-sectional survey
    Bavbek, S.
    Yilmaz, I.
    Celik, G.
    Aydin, O.
    Erkekol, F. O.
    Orman, A.
    Kurt, E.
    Ediger, D.
    Dursun, B.
    Abadoglu, O.
    Ozseker, F.
    Akkaya, E.
    Karakis, G. P.
    Canbakan, S.
    Yuksel, S.
    Misirligil, Z.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2012, 40 (04) : 225 - 230
  • [43] Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease
    Ban, Ga-Young
    Yang, Eun-Mi
    Ye, Young-Min
    Park, Hae-Sim
    CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (03)
  • [44] Not just snot: local inflammatory profiles in patients with aspirin-exacerbated respiratory disease differ from patients with aspirin-tolerant chronic rhinosinusitis
    Chiang, Simon
    Yu, Sophie E. E.
    Athni, Tejas S.
    Bergmark, Regan W.
    Maxfield, Alice Z.
    Roditi, Rachel E.
    Buchheit, Kathleen M.
    Lundberg, Marie
    Mitchell, Margaret B.
    Lee, Stella E. E.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (01) : 110 - 113
  • [45] Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease
    Bangert, Christine
    Villazala-Merino, Sergio
    Fahrenberger, Martin
    Krausgruber, Thomas
    Bauer, Wolfgang M.
    Stanek, Victoria
    Campion, Nicholas James
    Bartosik, Tina
    Quint, Tamara
    Regelsberger, Guenther
    Niederberger-Leppin, Verena
    Bock, Christoph
    Schneider, Sven
    Eckl-Dorna, Julia
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients
    Edward, Justin A.
    Sanyal, Mrinmoy
    Ramakrishnan, Vijay R.
    Le, Wei
    Nguyen, Alan L.
    Kingdom, Todd T.
    Hwang, Peter H.
    Nayak, Jayakar V.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2013, 3 (11) : 866 - 876
  • [47] Interleukin 16 and CCL17/thymus and activation-regulated chemokine in patients with aspirin-exacerbated respiratory disease
    Teran, Luis Manuel
    Ramirez-Jimenez, Fernando
    Soid-Raggi, Gabriela
    Velazquez, Juan Raymundo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 118 (02) : 191 - 196
  • [48] HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease
    Esmaeilzadeh, Hossein
    Nabavi, Mohammad
    Amirzargar, Ali Akbar
    Aryan, Zahra
    Arshi, Saba
    Bemanian, Mohammad Hassan
    Fallahpour, Morteza
    Mortazavi, Negar
    Rezaei, Nima
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2015, 29 (03) : E63 - E69
  • [49] Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease
    Tworek, Damian
    Kuprys-Lipinska, Izabela
    Pietruszewska, Wioletta
    Kuna, Piotr
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2012, 26 (06) : 428 - 432
  • [50] The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data
    Marion San Nicoló
    Catalina Högerle
    Donata Gellrich
    Katharina Eder
    Elisabeth Pfrogner
    Moritz Gröger
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 445 - 452